Sample PLR Article Directory Jersey

Thursday, September 29, 2016

Spanil

Spanil may be available in the countries listed below.

Ingredient matches for Spanil

Scopolamine

Scopolamine is reported as an ingredient of Spanil in the following countries:

Bangladesh

International Drug Name Search

Acanya

Acanya is a brand name of benzoyl peroxide/clindamycin topical, approved by the FDA in the following formulation(s):

ACANYA (benzoyl peroxide; clindamycin phosphate - gel; topical)

Manufacturer: DOW PHARM SCI

Approval date: October 23, 2008

Strength(s): 2.5%;1.2% ^[RLD]

Has a generic version of Acanya been approved?

No. There is currently no therapeutically equivalent version of Acanya available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Acanya. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

Compositions of clindamycin and benzoyl peroxide for acne treatment
Patent 5,733,886
Issued: March 31, 1998
Inventor(s): Baroody; Lloyd J. & Dow; Gordon J. & Dow; Debra A. & Lathrop; Robert
Assignee(s): Baroody; Lloyd J.
Dow; Gordon J.
Compositions suitable for the treatment of acne by topical application comprise clindamycin and benzoyl peroxide. Kits for preparing the compositions include a solution of clindamycin in a first container and a gel suspension of benzoyl peroxide in a second container. Each component is stored at a pH which promotes stability, and the combination of the two components provides a final composition having a pH which promotes stability and enhances viscosity.
Patent expiration dates:
- March 31, 2015
  ✓
  Patent use: TREATMENT OF ACNE
  ✓
  Drug product

Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
Patent 6,117,843
Issued: September 12, 2000
Inventor(s): Baroody; Lloyd J. & Dow; Gordon J. & Dow; Debra A. & Lathrop; Robert
Assignee(s): Baroody; Lloyd J.
Dow; Gordon J.
A pharmaceutical composition containing clindamycin and benzoyl peroxide is disclosed for the treatment of acne. The composition is stable for several months when stored at room temperature. Methods of preparing and of using the composition are disclosed.
Patent expiration dates:
- February 18, 2012
  ✓
  Drug product

Wednesday, September 28, 2016

Sinemet

SINEMET (carbidopa; levodopa - tablet; oral)

Manufacturer: MERCK SHARP DOHME

Approved Prior to Jan 1, 1982

Strength(s): 10MG;100MG ^[AB], 25MG;100MG ^[AB], 25MG;250MG ^[RLD]^[AB]

Has a generic version of Sinemet been approved?

Yes. The following products are equivalent to Sinemet:

CARBIDOPA AND LEVODOPA (carbidopa; levodopa tablet; oral)

Manufacturer: ACTAVIS ELIZABETH

Approval date: September 3, 1993

Strength(s): 10MG;100MG ^[AB], 25MG;100MG ^[AB], 25MG;250MG ^[AB]

Manufacturer: APOTEX INC

Approval date: June 2, 2008

Strength(s): 10MG;100MG ^[AB], 25MG;100MG ^[AB], 25MG;250MG ^[AB]

Manufacturer: MYLAN

Approval date: September 28, 2009

Strength(s): 10MG;100MG ^[AB], 25MG;100MG ^[AB], 25MG;250MG ^[AB]

Manufacturer: SUN PHARM INDS

Approval date: October 28, 2008

Strength(s): 10MG;100MG ^[AB], 25MG;100MG ^[AB], 25MG;250MG ^[AB]

Manufacturer: TEVA

Approval date: August 28, 1992

Strength(s): 10MG;100MG ^[AB], 25MG;100MG ^[AB], 25MG;250MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sinemet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Sinemet.

Has a generic version of Sinemet CR been approved?

Yes. The following products are equivalent to Sinemet CR:

CARBIDOPA AND LEVODOPA (carbidopa; levodopa tablet, extended release; oral)

Manufacturer: APOTEX

Approval date: June 16, 2004

Strength(s): 25MG;100MG ^[AB], 50MG;200MG ^[AB]

Manufacturer: IMPAX LABS

Approval date: May 14, 2004

Strength(s): 25MG;100MG ^[AB], 50MG;200MG ^[AB]

Manufacturer: MYLAN

Approval date: September 30, 1999

Strength(s): 50MG;200MG ^[AB]

Manufacturer: MYLAN

Approval date: April 21, 2000

Strength(s): 25MG;100MG ^[AB]

Manufacturer: SUN PHARM INDS

Approval date: August 23, 2007

Strength(s): 25MG;100MG ^[AB], 50MG;200MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sinemet CR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Sinemet CR.

Has a generic version of Solodyn been approved?

A generic version of Solodyn has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Solodyn and have been approved by the FDA:

minocycline hydrochloride tablet, extended release; oral

Manufacturer: BARR

Approval date: March 17, 2009

Strength(s): EQ 135MG BASE ^[AB], EQ 45MG BASE ^[AB], EQ 90MG BASE ^[AB]

Manufacturer: IMPAX LABS INC

Approval date: February 3, 2009

Strength(s): EQ 135MG BASE ^[AB], EQ 45MG BASE ^[AB], EQ 90MG BASE ^[AB]

Manufacturer: LUPIN LTD

Approval date: November 30, 2011

Strength(s): EQ 135MG BASE ^[AB], EQ 45MG BASE ^[AB], EQ 90MG BASE ^[AB]

Manufacturer: MATRIX LABS LTD

Approval date: July 20, 2010

Strength(s): EQ 135MG BASE ^[AB], EQ 45MG BASE ^[AB], EQ 90MG BASE ^[AB]

Manufacturer: SANDOZ

Approval date: August 13, 2009

Strength(s): EQ 135MG BASE ^[AB], EQ 45MG BASE ^[AB], EQ 90MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Solodyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

Method for the treatment of acne
Patent 5,908,838
Issued: June 1, 1999
Inventor(s): Gans; Eugene H.
Assignee(s): Medics Pharmaceutical Corporation
A method for the treatment of acne is provided which results in the reduction of vestibular side effects following administration of oral tetracycline antibiotics.
Patent expiration dates:
- February 19, 2018
  ✓
  Patent use: TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS

Minocycline oral dosage forms for the treatment of acne
Patent 7,541,347
Issued: June 2, 2009
Inventor(s): Wortzman; Mitchell & Plott; R. Todd & Bhatia; Kuljit & Patel; Bhiku
Assignee(s): Medicis Pharmaceutical Coropration
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
Patent expiration dates:
- April 2, 2027
  ✓
  Patent use: TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS

Minocycline oral dosage forms for the treatment of acne
Patent 7,544,373
Issued: June 9, 2009
Inventor(s): Wortzman; Mitchell & Plott; R. Todd & Bhatia; Kuljit & Patel; Bhiku
Assignee(s): Medicis Pharmaceutical Corporation
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
Patent expiration dates:
- April 2, 2027
  ✓
  Drug product

Minocycline oral dosage forms for the treatment of acne
Patent 7,790,705
Issued: September 7, 2010
Inventor(s): Wortzman; Mitchell & Plott; R. Todd & Bhatia; Kuljit & Patel; Bhiku
Assignee(s): Medicis Pharmaceutical Corporation
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
Patent expiration dates:
- June 24, 2025
  ✓
  Patent use: TREATMENT OF ACNE

Method for the treatment of acne
Patent 7,919,483
Issued: April 5, 2011
Inventor(s): Wortzman; Mitchell & Plott; R. Todd & Bhatia; Kuljit & Patel; Bhiku
Assignee(s): Medicis Pharmaceutical Corporation
A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
Patent expiration dates:
- March 7, 2027
  ✓
  Patent use: TREATMENT OF ACNE

Ingredient matches for Procid

Omeprazole

Omeprazole is reported as an ingredient of Procid in the following countries:

India

Probenecid

Probenecid is reported as an ingredient of Procid in the following countries:

Taiwan

International Drug Name Search

Optison

Generic Name: perflutren protein type a microsphere (Intravenous route)

per-FLOO-tren PROE-teen type A MYE-kroe-sfeers

Intravenous route(Suspension)

Serious cardiopulmonary reactions, including fatalities, have occurred during or following perflutren-containing microsphere administration. Monitor vital signs, electrocardiography, and cutaneous oxygen saturation during and for at least 30 minutes after perflutren-containing microsphere administration in patients with pulmonary hypertension or unstable cardiopulmonary conditions, and have resuscitation equipment and trained personnel available .

Commonly used brand name(s)

In the U.S.

Optison

Available Dosage Forms:

Suspension

Therapeutic Class: Diagnostic Agent, Cardiac Function

Uses For Optison

The albumin microspheres sonicated preparation is an ultrasound contrast agent. Ultrasound contrast agents are used to help provide a clear picture during ultrasound. Ultrasound is a special kind of diagnostic procedure. It uses high-frequency sound waves to create images or “pictures” of certain areas inside the body. The sound waves produced by the ultrasound equipment can be reflected (bounced off) by different parts of the body, like for example, the heart. As the sound waves return they are electronically converted into images on a television screen. Unlike x-rays, ultrasound does not involve ionizing radiation.

The albumin microspheres sonicated preparation contains very small gas-filled albumin microspheres that reflect the sound waves and help create a better picture. The albumin microspheres sonicated preparation is given by injection into a vein before ultrasound to help diagnose problems of the heart.

The albumin microspheres sonicated preparation is to be given only by or under the direct supervision of a doctor with specialized training in ultrasound procedures.

Before Using Optison

In deciding to use a diagnostic test, any risks of the test must be weighed against the good it will do. This is a decision you and your doctor will make. Also, other things may affect test results. For this test, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Studies on this agent have been done only in adult patients, and there is no specific information comparing use of albumin microspheres sonicated in children with use in other age groups.

Geriatric

Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. There is no specific information comparing use of albumin microspheres sonicated in the elderly with use in other age groups.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Proper Use of Optison

Your doctor may have special instructions for you in preparation for your test. If you do not understand the instructions you receive or if you have not received such instructions, check with your doctor in advance.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

Precautions While Using Optison

There are no special precautions to observe after having this test.

Optison Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Less common or rare

Chest pain; difficulty breathing or shortness of breath; itching; skin rash

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Dizziness; flushing of skin or sensation of warmth; headache; nausea and/or vomiting

Less common

Changes in taste; dryness of mouth; fatigue; pain at injection site; weakness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Optison side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Optison resources

Optison Side Effects (in more detail)
Optison Use in Pregnancy & Breastfeeding
Optison Drug Interactions
Optison Support Group
0 Reviews · Be the first to review/rate this drug

Optison MedFacts Consumer Leaflet (Wolters Kluwer)

Optison Prescribing Information (FDA)

Perflutren Professional Patient Advice (Wolters Kluwer)

Definity MedFacts Consumer Leaflet (Wolters Kluwer)

Definity Prescribing Information (FDA)

Thursday, September 29, 2016

Spanil

Ingredient matches for Spanil

Acanya

ACANYA (benzoyl peroxide; clindamycin phosphate - gel; topical)

Has a generic version of Acanya been approved?

Related Patents

See also...

Wednesday, September 28, 2016

Sinemet

SINEMET (carbidopa; levodopa - tablet; oral)

Has a generic version of Sinemet been approved?

CARBIDOPA AND LEVODOPA (carbidopa; levodopa tablet; oral)

Related Patents

See also...

Sinemet CR

SINEMET CR (carbidopa; levodopa - tablet, extended release; oral)

Has a generic version of Sinemet CR been approved?

CARBIDOPA AND LEVODOPA (carbidopa; levodopa tablet, extended release; oral)

Related Patents

See also...

Solodyn

SOLODYN (minocycline hydrochloride - tablet, extended release; oral)

Has a generic version of Solodyn been approved?

minocycline hydrochloride tablet, extended release; oral

Related Patents

See also...

Procid

Ingredient matches for Procid

Optison

Commonly used brand name(s)

Uses For Optison

Before Using Optison

Allergies

Pediatric

Geriatric

Pregnancy

Breast Feeding

Interactions with Medicines

Interactions with Food/Tobacco/Alcohol

Other Medical Problems

Proper Use of Optison

Dosing

Precautions While Using Optison

Optison Side Effects

More Optison resources